Penserra Capital Management’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Penserra Capital Management’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,731	Closed	-$36K	–	1441
2022 Q2	$36K	Sell	3,731 -644	-15%	-$6.36K	﹤0.01%	985
2022 Q1	$43K	Sell	4,375 -3,219	-42%	-$31.6K	﹤0.01%	1049
2021 Q4	$74K	Sell	7,594 -1,984	-21%	-$19.5K	﹤0.01%	925
2021 Q3	$93K	Sell	9,578 -2,053	-18%	-$20.2K	﹤0.01%	823
2021 Q2	$115K	Buy	+11,631	New	+$117K	﹤0.01%	760

Other funds holding LUXA

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Wolfswood Holdings New York $2.84M AUM 30.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

MMA

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Penserra Capital Management's LUXA Position: Q3 2022 in Review

Penserra Capital Management sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q3 2022, closing a stake of 3,731 shares — an estimated $36K sold.

Penserra Capital Management first reported a position in LUXA in Q2 2021 and held it in 5 quarters. The position peaked at $115K in Q2 2021. 72 funds tracked by Wall St. Rank hold LUXA as of Q3 2022.

Penserra Capital Management reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Penserra Capital Management sold 3,731 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q3 2022, an estimated $36K.
Penserra Capital Management first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q2 2021 and held it in 5 quarters.
Penserra Capital Management's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $115K in Q2 2021.
72 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.